Serum 25-hydroxyvitamin D concentrations in dogs with osteosarcoma do not differ from those of age- and weight-matched control dogs by Willcox, Jennifer L. et al.
UC Davis
UC Davis Previously Published Works
Title
Serum 25-hydroxyvitamin D concentrations in dogs with osteosarcoma do not differ from 
those of age- and weight-matched control dogs
Permalink
https://escholarship.org/uc/item/0mj7f02j
Authors
Willcox, JL
Hammett-Stabler, C
Hauck, ML
Publication Date
2016-11-01
DOI
10.1016/j.tvjl.2016.10.005
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Short Communication
Serum 25-hydroxyvitamin D concentrations in dogs with
osteosarcoma do not differ from those of age- and weight-matched
control dogs
Jennifer L. Willcox a,1, Catherine Hammett-Stabler b, Marlene L. Hauck a,*
a Veterinary Health Complex, North Carolina State University, 1060 William Moore Dr., Raleigh, NC 27607, USA
b Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27514, USA
A R T I C L E I N F O
Article history:
Accepted 10 October 2016
Keywords:
Bone
Cancer
Canine
Osteosarcoma
Vitamin D
A B S T R A C T
Vitamin D concentrations show an inverse correlation with incidence of certain tumors in people and
dogs. Additionally, human osteosarcoma has been associated with dysregulation of vitamin D-dependent
pathways. The study objective was to compare serum 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
in 20 dogs with osteosarcoma to age- and weight-matched control dogs. We hypothesized that dogs with
osteosarcoma would have lower serum 25-hydroxyvitamin D than control dogs. The mean 25-
hydroxyvitamin D3 concentrations for dogs with osteosarcoma and matched-controls were 34.95 ng/
mL and 33.85 ng/mL, respectively (P = 0.784). Based on these data, 25-hydroxyvitamin D insufficiency
might not be important in the pathogenesis of canine osteosarcoma.
© 2016 Published by Elsevier Ltd.
The primary role of vitamin D is calcium homeostasis, but in-
terest has developed in other roles and cancer risk. Epidemiologic
studies by Apperly (1941) identified an inverse correlation between
sun exposure and cancer risk in people. This spurred further re-
search, which identified an association between decreased 25-
hydroxyvitamin D (25[OH]D) concentrations and an increased risk
of certain tumor types such as colonic, prostatic, and mammary
cancers (Jacobs et al., 2016). Veterinary researchers have identi-
fied an increased overall risk of cancer, mast cell tumor, lymphoma,
and malignant hemoabdomen in dogs with significantly lower
25(OH)D (Gerber et al., 2004; Mellanby, 2016; Selting et al., 2016).
The relationship between vitamin D and neoplasia prompted us
to evaluate its involvement in the pathogenesis of canine osteo-
sarcoma. Vitamin D insufficiency could contribute to oncogenesis
of osteosarcomas, based on its role in several pathways utilized both
in health and tumor pathogenesis (Ryan et al., 2015). Therefore, we
investigated 25(OH)D2 /D3 concentrations, as markers of the active
form of vitamin D, in dogs with osteosarcoma compared to a
matched control population. We hypothesized that dogs with os-
teosarcoma dogs would have decreased 25(OH)D2 /D3 compared to
age- and weight-matched control dogs.
Serum samples from twenty dogs with histopathologically con-
firmed osteosarcoma were collected pre-treatment (surgery and/or
chemotherapy) at the North Carolina State University Veterinary
Health Complex (NCSU-VHC) or through the NCSU Clinical Trials
Core. All samples were acquired under an approved Institutional
Animal Care and Use Committee protocol (No. 11-134-O, 19 De-
cember 2011). Serum chemistry results were within the reference
range for 19/20 dogs with osteosarcoma; one dog had a slight el-
evation in blood urea nitrogen, but a normal creatinine concentration.
Twenty age- and weight-matched control dogs (with unremark-
able medical histories and physical evaluations) were paired with
osteosarcoma-affected dogs after stratification into groups (Table 1),
by factors that have been known to alter vitamin D metabolism
(Tryfonidou et al., 2003). Serum biochemical evaluation was per-
formed in both groups of dogs within 1 month of enrollment, and
study entry requirements included serum creatinine concentra-
tion in the reference range, since renal function has also been shown
to affect vitamin D (Mellanby, 2016).
Signalments of dogs with osteosarcoma included a median age
of 10 years and mean age of 9.58 ± 2.59 years. Most dogs were large
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Table 1
Age and bodyweight in dogs with osteosarcoma and control dogs.
Age Bodyweight
<25 kg
OSA n/control n
25–40 kg
OSA n/control n
>40 kg
OSA n/control n
<5 years 0/0 1/1 0/0
5–10 years 0/0 11/11 1/1
>10 years 1/1 6/6 0/0
OSA, osteosarcoma.
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breed (medianweight of 29.5 kg) and breeds were as follows: Golden
retriever (n = 5), Labrador retriever (n = 5), Rottweiler (n = 4), Mixed
breed (n = 3), Greyhound (n = 1), Great Dane (n = 1), and Stafford-
shire terrier (n = 1). Breeds represented in the control group included:
Labrador retriever (n = 7), Mixed breed (n = 3), Golden retriever (n = 2),
German shorthaired pointer (n = 1), American Staffordshire terrier
(n = 1), Australian cattledog (n = 1), Chow Chow (n = 1), Border collie
(n = 1), Airedale terrier (n = 1), and Boxer (n = 1). All dogs were spayed
or neutered.
Body condition score (BCS) was assessed using the American
Animal Hospital Association 1–9 scale for dogs. BCS was available
for nine of 20 osteosarcoma cases and 12 of 20 control dogs. Scoring
for dogs with osteosarcoma was as follows: seven dogs scored 5/9,
four dogs scored 6/9, and one dog scored 7/9. In the control group,
four dogs scored 5/9, three dogs scored 7/9, two dogs scored 4/9,
one dog scored 5.5/9, one dog scored 6/9, and one dog scored 8/9.
Blood samples were collected and serum aliquots were stored
at −80 °C until analysis. Analysis for vitamin D as 25(OH)D2 and
25(OH)D3 was performed using liquid chromatography tandemmass
spectrometry (LC-MS; Supplementary Table S1; McLendon Clini-
cal Laboratories, UNC Hospitals; Singh, 2010). Data were tested for
normality by the D’Agostino–Pearson omnibus test. After passing
normality testing, statistical analyses to compare 25(OH)D3 were
performed using a paired t test and an unpaired t test (Prism 7 for
Mac OS X; Graphpad Software) for BCS, and P values < 0.05 were
considered statistically significant.
The mean 25(OH)D3 concentrations for dogs with osteosar-
coma and matched-controls did not differ (34.95 ± 11.54 ng/mL vs.
33.85 ± 10.27 ng/mL; P = 0.784; Fig. 1). One control dog had mea-
surable 25(OH)D2 concentrations. BCS did not differ between groups
(P = 0.931).
Limitations of this study included small sample size, lack of
dietary and urinalysis information, and unmatched sex/hormone
status. Based on a post-hoc power analysis (Graphpad StatMate 2.0
for Windows; GraphPad Software) with an alpha of 0.05, we would
have been able to detect a difference in serum 25(OH)D3 concen-
trations of 9.95 ng/mL with 80% power; and a difference of 11.52 ng/
mL with 90% power. Dietary information would have strengthened
this study, as 25(OH)D3 is derived from the diet in dogs. Canine diets
vary in 25(OH)D3 content and can be impacted by owner
supplementation (Sharp et al., 2015; AAFCO, 2014). It is also known
that 25(OH)D can be affected by renal function as well as sex
hormone status, although all enrolled dogs were neutered (Sharp
et al., 2015; Mellanby, 2016).
Our findings do not exclude a role for vitamin D in both neo-
plastic and non-neoplastic disorders. Therefore, efforts to reach a
consensus on reference intervals and define target values, and an
accepted assay for the surrogate measure of vitamin D, 25(OH)D,
should be undertaken. While immunoassays provide increased con-
venience and efficiency, LC-MS offers an advantage in overall
sensitivity and may warrant future efforts in validation for veteri-
nary species (Wallace et al., 2010).
In summary, this study was unable to demonstrate a difference
in serum 25(OH)D2/D3 concentrations between dogs with osteo-
sarcoma and healthy control dogs. This suggests that mechanisms
aside from vitamin D insufficiency might be responsible for the
pathogenesis of osteosarcoma. However, larger controlled studies
are necessary to definitively elucidate the role of 25(OH)D2/D3 and
other potential drivers in canine osteosarcoma.
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Fig. 1. Serum 25-hydroxyvitamin D3 concentrations in dogs with osteosarcoma (OSA)
and control dogs. Bars represent mean and standard deviation within each group.
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